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The MicropatchTM solid dose skin delivery device combines the use of a solid stainless steel microneedle 
and the insertion of a solid drug loaded pellet which is inserted into the skin to the desired depth. The 
device has been developed in conjunction with Nemaura Pharma Limited (Loughborough, UK). This 
administration technique allows a drug dosage form ranging from several hundred microns to several 
millimetres to be inserted into the skin in a rapid user-independent manner1. The principle of the device is 
based upon the initial insertion of a super sharp stainless steel needle to breach the tough outer barrier of 
the skin, followed by a secondary drug carrier which contains the drug dosage form. The device allows the 
drug formulation to be inserted efficiently into the skin at any specified depth. The MicropatchTM device 
differs to conventional microneedle technology techniques such as the ‘poke and patch’, ‘coat and poke’ 
or biodegradable microneedles and can overcome the disadvantages and limitations associated with these 
techniques2-5. This includes the ability of the MicropatchTM to deliver a defined drug loading in to the skin, 
eliminating the poor reproducibility of dosing associated with large array microneedle patches. The 
instantaneous administration of the drug minimises the residual time required for the needles to be inside 
the skin, and therefore can lead to less irritation and therefore reduced user discomfort.  
 
The aim of this research is to evaluate the delivery of a model drug, Diclofenac Sodium, with a view to then 
evaluating Bio-Pharmaceuticals and vaccine delivery. Characterisation experiments have been conducted 
on full thickness Porcine skin to determine the drug penetration depth profile of the solid dose pellet and to 
illustrate various stages of pellet insertion. A USB microscope was used to capture the images. The time 
taken for the skin to reseal was also determined. This is illustrated in Figure 1. Dissolution of the pellet has 
also been conducted to determine the time taken for the diclofenac sodium drug to be released from the 
pellet. A 2.35 mm length conical pellet, 1.48 mm top diameter and 0.8 mm tip diameter pellet was used. 
The pellets were produced using a proprietary manufacturing technique developed by Nemaura Pharma, 
and yielded pellets weighing 23 mg.  
 
The results show that the MicropatchTM was able to successfully insert the pellet to a penetration depth of 
2 mm from the base of the MicropatchTM. The porcine skin was shown to reseal after 30 minutes (as shown 
in Figure 1. Image H). The dissolution study showed that a total drug release of diclofenac sodium occurred 
after 10 minutes (Figure 2). The results indicated that the MicropatchTM can be used as a new delivery 
system for diclofenac sodium and other biotheraputics. The delivery of various sized pellets can also be 
conducted by tailoring the MicropatchTM device.  
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Figure 1. Insertion of pellet into full thickness Porcine skin using the 
MicropatchTM. A shows the side view of the pellet, length: 2.35 mm, B: 
Top view (wall thickness at maximum: 0.4 mm) and C: underside of the 
tip. D: Insertion depth of 1 mm from MicropatchTM base, E: Insertion 
depth of 1.5 mm from MicropatchTM base, F: Image of skin after 10 
minutes at a total insertion depth of 2 mm from MicropatchTM base, G: 
insertion after 20 minutes, H: after 30 minutes (closure of skin) and I 
after 1 hour, using a USB microscope. 
 
 
 
Figure 2. Dissolution showing 
100% drug release after 10 
minutes. 
